AzTrials
AzTrials

Childhood ObesityNCT04047888

Assessment of Risk Factors for Childhood Obesity and Nutrition Education Intervention on Infant Growth and Development

An observational study of Childhood Obesity, run by The University of The West Indies at 1 site in Jamaica.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The period from conception to 2 years of age ('first 1000 days') has been recognized as a critical period for long-lasting programming effects on later obesity and associated NCD and a window of opportunity to implement intervention for reducing and treating childhood obesity. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Childhood Obesity
What is being tested?
Nutrition-based education on infant feeding and practices as well as Non nutrition-based educational message and Non nutrition-based educational message
How many people
152 participants
Where
1 siteJamaica
Study dates
28 Jan 2019to 31 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: The target populations from which participants will be selected will consist of pregnant women attending antenatal visits at Public Health Centers in Kingston and St. Andrew (KSA). Mothers will be recruited prior to 30-32 weeks gestation and study measurements will be made in the middle of the third trimesters

Who may be able to join

  • Women (18-40 years)
  • Women 30 -32 weeks gestation
  • First or second pregnancy
  • Healthy term infants ( > 37 completed weeks)
  • Infants with birthweight >2.5kg)

Who cannot join

  • Pre-gestational diabetes
  • Pre-gestational hypertension
  • Sickle cell disease
  • HIV infection,
  • Psychiatric disorder
  • Gestational diabetes
Show all 9Show fewer
  • Infants with congenital abnormalities
  • Infants with chromosomal disorders
  • Infants admitted in neonatal period > 48 hours

Trial locations and contacts

1 site in 1 country.

Carolyn R Taylor Bryan, PhD contact

876.553.7882

carolyn.taylorbryan@uwimona.edu.jm

Asha V Badaloo, PhD contact

876.927.1884

asha.badaloo@uwimona.edu.jm

Jamaica1 site, 1 recruiting
  • Tropical Metabolism Research Unit, TMRU University of the West Indies,

    Mona

    Carolyn R TaylorBryan, PhD, 876.927.1884, carolyn.taylorbryan@uwimona.edu.jm

    Asha V Badaloo, PhD, 876.927.1884, asha.badaloo@uwimona.edu.jm

    Recruiting

Other trials in Jamaica

About this study

Official title: Assessment of Risk Factors for Childhood Obesity and the Impact of a Nutrition-based Educational Intervention on Infant Feeding, Growth and Body Composition

The period from conception to 2 years of age ('first 1000 days') has been recognized as a critical period for long-lasting programming effects on later obesity and associated NCD and a window of opportunity to implement intervention for reducing and treating childhood obesity. However, there is a dearth of prospective intervention studies that address this nutritional problem in Jamaica and there are no reports of sustainable intervention.

Jamaica is a middle income country in which overweight and obesity in children are also increasing at an alarming rate. The investigators in Jamaica are seeking to provide a more comprehensive knowledge on the link between early life nutrition and later childhood health and to assess the impact of an intervention of infant feeding counselling/education in mothers on growth and body composition in their offspring.

Read the detailed description

At least 41 million children younger than 5 years are overweight or obese most of whom reside in low-income and middle-income countries (LMIC). Obese children tend to remain obese in adulthood predisposing to the huge personal health and economic burden of the non-communicable diseases (NCD).

Several early life factors identified to contribute to development of obesity and adverse metabolic profile; pre-pregnancy underweight and overweight, high weight gain in early pregnancy in addition to inappropriate infant feeding pattern and rapid weight gain in early life have major role.

The aims of the study are:1) to assess intrauterine and postnatal risk factors for childhood obesity in children followed from the second trimester in mother's pregnancy to age 1 year and 2) to assess the impact of a nutrition-based educational intervention on infant feeding, growth and body composition in the first year of life.

This study design is a cluster randomized clinical trial with key outputs being : 1) The use of deuterium dilution method to provide new data on body composition of mothers from during pregnancy and during infancy in addition to obtain accurate measurement of breastmilk intake 2) new data on the relationship between maternal body composition and/or infant body composition and non-communicable disease risk factors; 3) new data on the impact of a nutrition-based educational on infant's growth and body composition.

Being tested
Nutrition-based education on infant feeding and practices as well as Non nutrition-based educational message, Non nutrition-based educational message
Medical subject headings
Pediatric Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nutrition-based education on infant feeding and practices as well as Non nutrition-based educational messageOther

    60 minute educational message at each visit

  • Non nutrition-based educational messageOther

    No nutrition-based education on infant feeding and practices

Study groups in NCT04047888
Study groupRoleWhat they receive
Intervention GroupMothers and children in this group will have measurements, questionnaire administration. The children will have routine child care at their health center and mothers will have a 60 minute nutrition-based and non-nutrition based educational message
Receives: Other: Nutrition-based education on infant feeding and practices as well as Non nutrition-based educational message
Control GroupMothers and babies will have measurements and questionnaire administration and children will receive routine child care at their health centers. These mothers will receive a non-nutrition based educational message only.
Receives: Other: Non nutrition-based educational message

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feeding Questionnaire - first assessment

    This questionnaire will describe breastfeeding and complementary feeding practices. Proportions will be used to compare responses between the intervention and control groups. A scale will not be used.

    Measured: 2 weeks old

  2. Feeding Questionnaire - second assessment

    This questionnaire will describe breastfeeding and complementary feeding practices. Proportions will be used to compare responses between the intervention and control groups. A scale will not be used.

    Measured: 4 weeks old

  3. Feeding Questionnaire - third assessment

    This questionnaire will describe breastfeeding and complementary feeding practices. Proportions will be used to compare responses between the intervention and control groups. A scale will not be used.

    Measured: 3 months old

  4. Feeding Questionnaire - fourth assessment

    This questionnaire will describe breastfeeding and complementary feeding practices. Proportions will be used to compare responses between the intervention and control groups. A scale will not be used.

    Measured: 6 months old

  5. Feeding Questionnaire - fifth assessment

    This questionnaire will describe breastfeeding and complementary feeding practices. Proportions will be used to compare responses between the intervention and control groups. A scale will not be used.

    Measured: 12 months old

  6. Child's lean mass and fat mass (body composition) determined using skin fold measurements - first assessment

    Child's fat mass and lean mass (body composition) determined using skin fold callipers

    Measured: 6 months old

  7. Child's fat mass and lean mass (body composition) determined using Bioelectrical Impedance Analysis (BIA) - first assessment

    Child's fat mass and lean mass (body composition) determined using a Bioelectrical Impedance Analyzer

    Measured: 6 months old

  8. Child's mid-upper arm circumference - first assessment

    Child's mid-upper arm circumference measured using a tape measure

    Measured: 6 months

  9. Child's lean mass and fat mass (body composition) determined using skin fold measurements - second assessment

    Child's fat mass and lean mass (body composition) determined using skin fold callipers

    Measured: 12 months old

  10. Child's fat mass and lean mass (body composition) determined using Bioelectrical Impedance Analysis (BIA) - second assessment

    Child's fat mass and lean mass (body composition) determined using a Bioelectrical Impedance Analyzer

    Measured: 12 months old

  11. Child's mid-upper arm circumference - second assessment

    Child's mid-upper arm circumference measured using a tape measure

    Measured: 12 months old

  12. Child's fat mass and lean mass (body composition) determined using deuterium dilution method - first assessment

    Measurement of fat mass and lean mass (body composition) using the deuterium dilution method

    Measured: 6 months old

  13. Child's fat mass and lean mass (body composition) determined using deuterium dilution method - second assessment

    Measurement of fat mass and lean mass (body composition) using the deuterium dilution method

    Measured: 12 months old

  14. Child's weight in kilograms - first assessment

    Child's weight measured using a digital scale

    Measured: 4 weeks old

  15. Child's weight in kilograms - second assessment

    Child's weight measured using a digital scale

    Measured: 3 months old

  16. Child's weight in kilograms - third assessment

    Child's weight measured using a digital scale

    Measured: 6 months old

  17. Child's weight in kilograms - fourth assessment

    Child's weight measured using a digital scale

    Measured: 12 months old

  18. Child's length in centimeters - first assessment

    Child's length measured using a stadiometer

    Measured: 4 weeks old

  19. Child's length in centimeters - second assessment

    Child's length measured using a stadiometer

    Measured: 3 months old

  20. Child's length in centimeters - third assessment

    Child's length measured using a stadiometer

    Measured: 6 months old

  21. Child's length in centimeters - fourth assessment

    Child's length measured using a stadiometer

    Measured: 12 months old

  22. Child's fat mass and lean mass (body composition) determined using Dual-energy X-ray absorptiometry (DEXA)

    A whole body DEXA scan will be done as described by the International Atomic Energy Agency. A scan takes about 7 minutes.

    Measured: 12 months old

  23. Child's fat mass and lean mass (body composition) determined using Air Displacement Plethysmography - first assessment

    Measurement of child's fat mass and lean mass (body composition) using the Air Displacement Plethysmography

    Measured: 4 weeks old

  24. Child's fat mass and lean mass (body composition) determined using the Air Displacement Plethysmography - second assessment

    Measurement of child's fat mass and lean mass (body composition) using the Air Displacement Plethysmography

    Measured: 3 months old

  25. Child's fat mass and lean mass (body composition) determined using the Air Displacement Plethysmography - third assessment

    Measurement of child's fat mass and lean mass (body composition) using the Air Displacement Plethysmography

    Measured: 6 months old

Secondary outcomes (19)
  1. Screen time / sleep time questionnaire - first assessment

    This will describe total duration of sleep time and screen viewing time. Child's feeding pattern during the night will also be assessed (if the child fed or did not feed). Proportions will be used to compare responses between the intervention and control groups. Absolute values will also be compared for some questions. A scale will not be used.

    Measured: 3 months old

  2. Screen time / sleep time questionnaire - second assessment

    This will describe total duration of sleep time and screen viewing time. Child's feeding pattern during the night will also be assessed (if the child fed or did not feed). Proportions will be used to compare responses between the intervention and control groups. Absolute values will also be compared for some questions. A scale will not be used.

    Measured: 6 months old

  3. Screen time / sleep time questionnaire - third assessment

    This will describe total duration of sleep time and screen viewing time. Child's feeding pattern during the night will also be assessed (if the child fed or did not feed). Proportions will be used to compare responses between the intervention and control groups. Absolute values will also be compared for some questions. A scale will not be used.

    Measured: 12 months old

  4. Breastmilk intake in child

    To determine the amount of breastmilk consumed. The mother will consume a carefully weighed dose of deuterium. Saliva samples will be collected from the mother and her infant at baseline and at 2 timepoints between 1 and 14 days following dose consumption. Deuterium enrichment will be measured by Fourier transform infrared (FTIR) Spectrometry.

    Measured: 3 months old

  5. Mother's fat mass and lean mass (body composition) determined using deuterium (2H) dilution technique - first assessment

    Fat mass and lean mass (body composition)determined using deuterium (2H) dilution technique

    Measured: 30-32 weeks gestation

  6. Mother's fat mass and lean mass (body composition) determined using skin fold measurements - first assessment

    Fat mass and lean mass (body composition) measured using skin fold callipers

    Measured: 30-32 weeks gestation

  7. Mother's fat mass and lean mass (body composition) determined using Bioelectrical Impedance Analysis (BIA) - first assessment

    Fat mass and lean mass (body composition) measured using BIA analyzer

    Measured: 30-32 weeks gestation

  8. Mother's weight - first assessment

    Mother's weight measured using a digital scale

    Measured: 30-32 weeks gestation

  9. Mother's height

    Mother's height measured using a stadiometer

    Measured: 30-32 weeks gestation

  10. Mother's mid-upper arm circumference - first assessment

    Mother's mid-upper arm circumference measured using a tape measure

    Measured: 30-32 weeks gestation

  11. Mother's fat mass and lean mass (body composition) determined using skin fold measurements - second assessment

    Mother's fat mass and lean mass (body composition) determined using skin fold calliper

    Measured: 3 months post natally

  12. Mother's fat mass and lean mass (body composition) determined using Bioelectrical Impedance Analysis (BIA) - second assessment

    Fat mass and lean mass (body composition) determined measured using BIA analyzer

    Measured: 3 months post natally

  13. Mother's fat mass and lean mass (body composition) using deuterium dilution - second assessment

    Fat mass and lean mass (body composition) determined using deuterium dilution during breastmilk assessment

    Measured: 3 months post natally

  14. mother's weight - second assessment

    mothers weight measured using a scale

    Measured: 3 months post natally

  15. mother's mid-upper arm circumference - second assessment

    mother's mid-upper arm circumference measured using a tape measure

    Measured: 3 months post natally

  16. Mother's fat mass and lean mass (body composition) determined using skin fold measurements - third assessment

    Mother's fat mass and lean mass (body composition) determined using skin fold callipers

    Measured: 12 months post natally

  17. Mother's fat mss and lean mass (body composition) determined using Bioelectrical Impedance Analysis (BIA) - third assessment

    mother's fat mass and lean mass (body composition) determined using BIA analyzer

    Measured: 12 months post natally

  18. mother's weight - third assessment

    mothers weight measured using a scale

    Measured: 12 months post natally

  19. mother's mid-upper arm circumference - third assessment

    mother's mid-upper arm circumference measured using a tape measure

    Measured: 12 months post natally

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2019
  2. Study start28 Jan 2019
  3. Primary completion31 Dec 2021 (estimated)
  4. Study completion31 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
152 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04047888
Sponsor's protocol ID
EC115-17/18
Status last verified
Feb 2019
First submitted
15 Jun 2019
Last updated
7 Aug 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Childhood Obesity, run by The University of The West Indies at 1 site in Jamaica.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Jamaica. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Carolyn R Taylor Bryan, PhD (876.553.7882, carolyn.taylorbryan@uwimona.edu.jm), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feeding Questionnaire - first assessment (time frame: 2 weeks old). The study lists 25 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in